Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Article in English | MEDLINE | ID: mdl-34471418

ABSTRACT

Kava (Piper methysticum Forst) is a popular and favorable edible medicinal herb which was traditionally used to prepare a nonfermented beverage with relaxant beneficial for both social and recreational purposes. Numerous studies conducted on kava have confirmed the presence of kavalactones and flavokawains, two major groups of bioactive ingredients, in this miraculous natural plant. Expectedly, both kavalactone and flavokawain components exhibited potent antianxiety and anticancer activities, and their structure-activity relationships were also revealed. However, dozens of clinical data revealed the hepatotoxicity effect which is indirectly or directly associated with kava consumption, and most of the evidence currently seems to point the compounds of flavokawains in kava were responsible. Therefore, our aim is to conduct a systematic review of kavalactones and flavokawains in kava including their biological activities, structure-activity relationships, and toxicities, and as a result of our systematic investigations, suggestions on kava and its compounds are supplied for future research.

2.
Food Chem Toxicol ; 157: 112581, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34562529

ABSTRACT

Lung cancer caused one-quarter of all cancer deaths that was more than other cancers. Chemoprevention is a potential strategy to reducing lung cancer incidence and death, and the effective chemopreventive agents are needed. We investigated the efficacy and mechanism of garlic oil (GO), the garlic product, in the chemoprevention of tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung cancer in A/J mice and MRC-5 cell models in the present study. As a result, it was demonstrated that GO significantly inhibited the NNK-induced lung cancer in vivo and protected MRC-5 cells from NNK-induced cell damage. GO could induce the expressions of the phase II drug-metabolizing enzymes, including NAD(P)H: quinone oxidoreductase 1 (NQO-1), glutathione S-transferase alpha 1 (GSTA1), and antioxidative enzymes heme oxygenase-1 (HO-1). These results supported the potential of GO as a novel candidate agent for the chemoprevention of tobacco carcinogens induced lung cancer.


Subject(s)
Allyl Compounds/therapeutic use , Carcinogenesis/drug effects , Lung Neoplasms/prevention & control , Nitrosamines/toxicity , Sulfides/therapeutic use , Allyl Compounds/pharmacology , Animals , Benzothiazoles/metabolism , Blotting, Western , Comet Assay , Female , Flow Cytometry , Lung Neoplasms/chemically induced , Male , Membrane Potential, Mitochondrial/drug effects , Mice , Nitrosamines/antagonists & inhibitors , Reactive Oxygen Species/metabolism , Real-Time Polymerase Chain Reaction , Sulfides/pharmacology
3.
J Sep Sci ; 44(14): 2705-2716, 2021 Jul.
Article in English | MEDLINE | ID: mdl-33951745

ABSTRACT

Kava, the rhizomes and roots of Piper methysticum Forst, is a popular edible medicinal herb traditionally used to prepare beverages for anxiety reduction. Since the German kava ban has been lifted by the court, the quality evaluation is particularly important for its application, especially the flavokawains which were believed to be responsible for hepatotoxicity. Now, by employing two different standard references and four different methods to calculate the relative correction factors, eight different quantitative analyses of multicomponents by single-marker methods have been developed for the simultaneous determination of eight major kavalactones and flavokawains in kava. The low standard method difference on quantitative measurement of the compounds among the external standard method and ours confirmed the reliability of the mentioned methods. A radar plot clearly illustrated that the contents of dihydrokavain and kavain were higher, whereas flavokawains A and B were lower in different kava samples. Only one of eight samples did not detect flavokawains that may be related to hepatotoxicity. In summary, by using different agents as an internal standard reference, the developed methods were believed as a powerful analytical tool not only for the qualitative and quantitative of kava constituents but also for the other multicomponents when authentic standard substances were unavailable.


Subject(s)
Chalcone/analogs & derivatives , Kava/chemistry , Pyrones , Chalcone/analysis , Chalcone/chemistry , Chromatography, High Pressure Liquid/methods , Dietary Supplements , Lactones/analysis , Lactones/chemistry , Phytotherapy , Plant Extracts/analysis , Plant Extracts/chemistry , Plant Roots/chemistry , Plants, Medicinal , Pyrones/analysis , Pyrones/chemistry
4.
Planta Med ; 86(8): 538-547, 2020 May.
Article in English | MEDLINE | ID: mdl-32294789

ABSTRACT

Isoliquiritigenin, a flavonoid extracted from licorice root, has been shown to be active against most cancer cells; however, its antitumor activity is limited by its poor water solubility. The aim of this study was to develop a stable isoliquiritigenin nanosuspension for enhanced solubility and to evaluate its in vitro cytostatic activity in A549 cells. The nanosuspension of isoliquiritigenin was prepared through wet media milling with HPC SSL (hydroxypropyl cellulose-SSL) and PVP K30 (polyinylpyrrolidone-K30) as stabilizers, and the samples were then characterized according to particle size, zeta-potential, SEM (scanning electron microscopy), TEM (transmission electron microscopy), DSC (differential scanning calorimetry), XRPD (X-ray powder diffraction), FTIR (Fourier transform infrared spectroscopy), XPS (X-ray photoelectron spectroscopy), and in vitro release. The isoliquiritigenin nanosuspension prepared with HPC SSL and PVP K30 had particle sizes of 238.1 ± 4.9 nm and 354.1 ± 9.1 nm, respectively. Both nanosuspensions showed a surface charge of approximately - 20 mV and a lamelliform or ellipse shape. The dissolution of isoliquiritigenin from the 2 nanosuspensions was markedly higher than that of free isoliquiritigenin. In vitro studies on A549 cells indicated that the cytotoxicity and cellular uptake significantly improved after treatment with both nanosuspensions in comparison to the isoliquiritigenin solution. Furthermore, cell apoptosis analysis showed a 7.5 - 10-fold increase in the apoptosis rate induced by both nanosuspensions compared with pure drug. However, the cytotoxicity of pure drug and nanosuspension on normal cells (HELF) was lower, which indicated both isoliquiritigenin nanosuspensions have low toxicity to normal cells. Therefore, the isoliquiritigenin nanosuspension prepared with HPC SSL and PVP K30 as stabilizers may be a promising approach to improve the solubility and cytostatic activity of isoliquiritigenin.


Subject(s)
Lung Neoplasms , Nanoparticles , A549 Cells , Biological Availability , Chalcones , Drug Stability , Humans , Microscopy, Electron, Scanning , Particle Size , Solubility , Suspensions , X-Ray Diffraction
5.
Free Radic Biol Med ; 117: 228-237, 2018 03.
Article in English | MEDLINE | ID: mdl-29428410

ABSTRACT

Small-molecule inhibitors that block the Keap1-Nrf2 protein-protein interactions are being intensely pursued as a new therapeutic strategy for oxidative stress-related diseases, such as cancer, diabetes, Alzheimer's disease, arteriosclerosis, inflammation and myocarditis. However, there are not enough studies on antioxidant treatments using small molecules in myocarditis. We herein provided a series of novel hydronaphthoquinones as the Keap1-Nrf2 interaction inhibitors targeting LPS-induced myocarditis both in vitro and in vivo. These compounds were designed through an in-silico fragment growing approach based on our previous reported compound, S47 (1). The new compounds were predicted to form additional hydrogen bonds with the S363 residue, leading to higher inhibitory activity. Among these new derivatives, compounds S01 and S05 emerged as inhibitors with significant biochemical potency, as determined by fluorescent anisotropy assay and confirmed by surface plasmon resonance (SPR) and differential scanning fluorimetry (DSF) assays. These inhibitors can dose-dependently protect the H9c2 cardiac cells against LPS-induced injury (100% at 2 µM and 4 µM) and effectively prolong survival or save the life of LPS-injured mice. Mechanistic studies showed that these inhibitors could release Nrf2 in H9c2 cells and LPS-inflammatory mouse models and translocate into the nucleus in a dose-response manner, which significantly increased the downstream genes (HO-1, NQO-1) and the pro-inflammatory cytokines (TNF-α, IL-1ß, IL-6), while ROS production dramatically decreased. Their protective effects and the mechanism of action were further confirmed by siNrf2 transfected experiment. Collectively, the novel hydronaphthoquinones can be used as promising lead compounds for the study of Keap1-Nrf2 protein-protein interactions and further anti-myocarditis drug development.


Subject(s)
Antioxidants/pharmacology , Drug Discovery/methods , Kelch-Like ECH-Associated Protein 1/drug effects , Myocarditis , NF-E2-Related Factor 2/drug effects , Animals , Drug Evaluation, Preclinical/methods , Mice , Mice, Inbred C57BL , Naphthoquinones/pharmacology , Protein Binding/drug effects , Rats
6.
Zhong Yao Cai ; 38(10): 2176-9, 2015 Oct.
Article in Chinese | MEDLINE | ID: mdl-27254933

ABSTRACT

OBJECTIVE: The volatile components of the Hui formula "Ha Hei Lili" were extracted by steam distillation extraction (SD) and supercritical CO2 fluid extraction, and the structures were analyzed and identified by GC-MS. METHODS: The GC-MS conditions were set as follows: Rxi-5Sil MS quartz capillary column (30 m x 0.25 mm, 0.25 µm), the initial temperature of 50 degrees C to keep 1 min, to 10 degrees C/min heating to 120 degrees C, maintained 3 min, then to 3 degrees C/min heating to 200 degrees C, maintained 3 min, and then to 5 degreesC/min heating to 290 degrees C, maintained until completion of analysis; helium as the carrier gas, column flow rate 1.0 ml/min, split ratio 25: 1, inlet temperature 250 degrees C, EI ionization source 70 eV, ion source temperature 230 degrees C, scan range of m/z 35 - 500. RESULTS: Yield of volatile oil were 0.21% and 5.44% extracted by SD and SFE methods, respectively; and for SD method, 36 kinds of compounds were identified, accounted for 87.02% of total mass of volatile oil; for SFE method, 38 kinds of constituents were identified, accounted for 97.47% of total mass of volatile oil. CONCLUSION: The type of constituents contained in the volatile oil extracted by SD and SFE methods are totally different; and GC-MS can be used to identify the structures and relative content of volatile components, the results of this study can provide an experimental basis for development and utilization of Hui formula "Ha Hei Lili".


Subject(s)
Drugs, Chinese Herbal/chemistry , Oils, Volatile/chemistry , Phytochemicals/chemistry , Chromatography, Supercritical Fluid , Distillation , Gas Chromatography-Mass Spectrometry , Oils, Volatile/isolation & purification , Phytochemicals/isolation & purification , Steam , Temperature
7.
Pharm Biol ; 51(6): 744-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23527896

ABSTRACT

CONTEXT: Primary dysmenorrhea is one of the most frequent gynecological disorders in young women. Chinese herbal medicine has the advantage in terms of multi-targeting efficacy, lower toxicity, as well as lower cost. Core licorice is the hard and atropurpureus heart part in root and rootstock of Glycyrrhiza uralensis Fisch (Leguminosae), having a therapeutic effect on dysmenorrhea. OBJECTIVE: This experiment indicated the spasmolytic effect of core licorice aqueous extract (CLE) on spontaneous rhythmic contractions and spasmogen-provoked contractions of stilbestrol primed, estrogen-dominated, non-pregnant mouse isolated uterine horns and its spasmolytic mechanism. MATERIALS AND METHODS: We investigated the spasmolytic effect of CLE (0.025-0.1 mg/mL) on spontaneous contractions and potassium chloride (KCl, 40 mM), acetylcholine (ACh, 5 µg/mL), carbachol (CCh, 5 µg/mL), oxytocin (OT, 2 U/L) or bradykinin (5 ng/mL)-provoked contractions of mouse isolated uterine horns. Contractions were recorded by tension force transducers using Biolap 420F software on a PC. RESULTS: Our present study showed that graded, escalated concentrations of CLE (0.025-0.1 mg/mL) significantly inhibited the amplitude of spontaneous phasic contractions (15.03-55.10%), as well as the contractions produced by KCl (40 mM; 20.16-53.99%), ACh (5 µg/mL; 14.65-48.32%), CCh (5 µg/mL; 38.40-76.70%), OT (2 U/L; 21.53-58.49%) or bradykinin (5 ng/mL; 58.01-79.44%) of the estrogen-dominated isolated mice uterine horn preparations in a concentration-related manner. DISCUSSION AND CONCLUSION: The spasmolytic effect of CLE observed in the present study lends pharmacological support to the traditional use of core licorice in the management, control and treatment of primary dysmenorrhea.


Subject(s)
Glycyrrhiza uralensis/chemistry , Plant Extracts/pharmacology , Uterine Contraction/drug effects , Uterus/drug effects , Animals , Dose-Response Relationship, Drug , Dysmenorrhea/drug therapy , Female , Mice , Mice, Inbred ICR , Parasympatholytics/administration & dosage , Parasympatholytics/isolation & purification , Parasympatholytics/pharmacology , Plant Extracts/administration & dosage , Plant Roots , Uterus/metabolism
8.
Med Res Rev ; 33(3): 554-98, 2013 May.
Article in English | MEDLINE | ID: mdl-22430881

ABSTRACT

Fragment-based drug design (FBDD) is a promising approach for the discovery and optimization of lead compounds. Despite its successes, FBDD also faces some internal limitations and challenges. FBDD requires a high quality of target protein and good solubility of fragments. Biophysical techniques for fragment screening necessitate expensive detection equipment and the strategies for evolving fragment hits to leads remain to be improved. Regardless, FBDD is necessary for investigating larger chemical space and can be applied to challenging biological targets. In this scenario, cheminformatics and computational chemistry can be used as alternative approaches that can significantly improve the efficiency and success rate of lead discovery and optimization. Cheminformatics and computational tools assist FBDD in a very flexible manner. Computational FBDD can be used independently or in parallel with experimental FBDD for efficiently generating and optimizing leads. Computational FBDD can also be integrated into each step of experimental FBDD and help to play a synergistic role by maximizing its performance. This review will provide critical analysis of the complementarity between computational and experimental FBDD and highlight recent advances in new algorithms and successful examples of their applications. In particular, fragment-based cheminformatics tools, high-throughput fragment docking, and fragment-based de novo drug design will provide the focus of this review. We will also discuss the advantages and limitations of different methods and the trends in new developments that should inspire future research.


Subject(s)
Computational Biology/methods , Drug Design , 14-alpha Demethylase Inhibitors/chemical synthesis , Catalytic Domain , Cyclophilin A/antagonists & inhibitors , Drug Evaluation, Preclinical/methods , Ligands , Molecular Docking Simulation , Nitric Oxide Synthase Type I/antagonists & inhibitors , Receptors, Drug/chemistry , Serotonin 5-HT1 Receptor Antagonists/chemical synthesis , Software , Structure-Activity Relationship
9.
Curr Med Chem ; 18(28): 4389-409, 2011.
Article in English | MEDLINE | ID: mdl-21861816

ABSTRACT

Topoisomerase I (Top1) represents an important target of active interest in developing novel anticancer agents. Camptothecin derivatives are the only class of clinically approved Top1 inhibitors and show potent efficacy in anticancer therapy. However, there are also several major limitations for them, such as poor chemical stability, drug resistance, long infusions and side effects. To overcome the drawbacks of the camptothecins, the discovery of non-camptothecin Top1 inhibitors has recently emerged as a promising field to find better antitumor agents. Non-camptothecin Top1 inhibitors are expected to possess better chemical stability, different therapeutic activities and antitumor spectrum, improved pharmacokinetics and lower toxicity. This review focuses on various strategies that were used in the discovery of non-camptothecin Top1 inhibitors. In particular, the chemical scaffolds, structure-activity relationships and binding modes of the newly identified non-camptothecin Top1 inhibitors are discussed in detail.


Subject(s)
DNA Topoisomerases, Type I/chemistry , Drug Design , Carbazoles/chemistry , Carbazoles/pharmacology , DNA Topoisomerases, Type I/metabolism , Drug Evaluation, Preclinical , Enzyme Activation/drug effects , Humans , Isoquinolines/chemistry , Isoquinolines/pharmacology , Phenanthridines/chemistry , Phenanthridines/pharmacology , Pyridines/chemistry , Pyridines/pharmacology , Quinazolines/chemistry , Quinazolines/pharmacology , Structure-Activity Relationship , Topoisomerase I Inhibitors/chemistry , Topoisomerase I Inhibitors/pharmacology
10.
Chem Biodivers ; 7(12): 2869-79, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21161999

ABSTRACT

Three new compounds, 1-3, and 20 known compounds were isolated from the AcOEt and BuOH extract of edible Opuntia Milpa Alta. The petroleum ether extract was examined by GC and MS. A total of 26 compounds were identified, representing 95.6% of the total extract, phytosterol (36.03%) being the most abundant component, and polyunsaturated fatty acids (18.57%) represented the second largest group, followed by phytol (12.28%), palmitic acid, palmitate (13.54%), vitamin E (4.51%), and other compounds (7.47%). The effects of various extracts from edible Opuntia Milpa Alta (petroleum ether extract, AcOEt extract, BuOH extract, aqueous extract, H2O parts) and the positive control (received dimethylbiguanide) were tested on streptozotocin (STZ)-induced diabetic mice. The results indicated that all the treatment groups could significantly decrease blood glucose levels in STZ-induced diabetic mice compared to the model control group (P<0.01), except the aqueous extract group (P<0.05). Especially, the petroleum ether extract group and the positive control group showed remarkable decrease of blood glucose levels. Taken together, the results indicate that the petroleum ether extract is the major hypoglycemic part in edible Opuntia Milpa Alta, which may be developed to a potential natural hypoglycemic functional ingredient.


Subject(s)
Hypoglycemic Agents/chemistry , Opuntia/chemistry , Tartrates/chemistry , Animals , Blood Glucose/analysis , Diabetes Mellitus, Experimental/drug therapy , Gas Chromatography-Mass Spectrometry , Hypoglycemic Agents/isolation & purification , Hypoglycemic Agents/therapeutic use , Magnetic Resonance Spectroscopy , Mice , Molecular Conformation , Plant Extracts/chemistry , Plant Stems/chemistry , Tartrates/isolation & purification , Tartrates/therapeutic use
11.
J Med Chem ; 53(21): 7521-31, 2010 Nov 11.
Article in English | MEDLINE | ID: mdl-20942490

ABSTRACT

Human topoisomerase I (TopoI) is recognized as a valuable target for the development of effective antitumor agents. Structure-based virtual screening was applied to the discovery of structurally diverse TopoI inhibitors. From 23 compounds selected by virtual screening, a total of 14 compounds were found to be TopoI inhibitors. Five hits (compounds 1, 14, 20, 21, and 23) also showed moderate to good in vitro antitumor activity. These novel structures can be considered as good starting points for the development of new antitumor lead compounds. Hit 20 (evodiamine) was chosen for preliminary structure-activity relationship studies. Various groups, including alkyl, benzoyl, benzyl and ester, were introduced to the indole nitrogen atom of evodiamine. The substituted benzoyl groups were found to be favorable for the antitumor activity and spectrum. The 4-Cl benzoyl derivative, compound 29u, was the most active one with IC(50) values in the range 0.049-2.6 µM.


Subject(s)
Antineoplastic Agents/chemical synthesis , Models, Molecular , Plant Extracts/chemical synthesis , Quinazolines/chemical synthesis , Topoisomerase I Inhibitors/chemical synthesis , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Drug Screening Assays, Antitumor , Humans , Plant Extracts/chemistry , Plant Extracts/pharmacology , Protein Binding , Quinazolines/chemistry , Quinazolines/pharmacology , Structure-Activity Relationship , Topoisomerase I Inhibitors/chemistry , Topoisomerase I Inhibitors/pharmacology
12.
Yao Xue Xue Bao ; 45(8): 966-75, 2010 Aug.
Article in Chinese | MEDLINE | ID: mdl-21351583

ABSTRACT

In recent years, the incidence and mortality rate of invasive fungal infection have increased dramatically, and it is of great significance to develop novel antifungal agents with new chemical structure and new mode of action. In this review, novel antifungal lead compounds reported from 2007 to 2009 are reviewed. Moreover, their chemical structures, antifungal activities and structure-activity relationships have been summarized, which can provide useful information for future study of antifungal agents.


Subject(s)
Antifungal Agents/chemical synthesis , Fungi/drug effects , Antifungal Agents/chemistry , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Heterocyclic Compounds/chemical synthesis , Heterocyclic Compounds/chemistry , Heterocyclic Compounds/pharmacology , Humans , Lipopeptides/chemistry , Lipopeptides/pharmacology , Lipopeptides/therapeutic use , Molecular Structure , Mycoses/drug therapy , Nitriles/chemistry , Nitriles/pharmacology , Nitriles/therapeutic use , Plant Extracts/chemical synthesis , Plant Extracts/chemistry , Plant Extracts/isolation & purification , Plant Extracts/pharmacology , Plants, Medicinal/chemistry , Pyridines/chemistry , Pyridines/pharmacology , Pyridines/therapeutic use , Quinazolines/chemistry , Quinazolines/pharmacology , Quinazolines/therapeutic use , Quinones/chemical synthesis , Quinones/chemistry , Quinones/pharmacology , Structure-Activity Relationship , Thiazoles/chemistry , Thiazoles/pharmacology , Thiazoles/therapeutic use , Triazoles/chemistry , Triazoles/pharmacology , Triazoles/therapeutic use
13.
BMC Complement Altern Med ; 8: 51, 2008 Sep 15.
Article in English | MEDLINE | ID: mdl-18793392

ABSTRACT

BACKGROUND: Soft tissue injury imposes major public health burdens worldwide. The positive effect of China's Tibetan medicine and the Lamiophlomis rotata-based herbal Pain Relieving Plaster (PRP) on healing closed soft tissue injury (CSTI) has been reported. The herbs contained in Plaster are also referred as 'blood-activating and stasis-dispelling' in herbal medicine. The formula of the plaster contains four China's Tibetan medical herbs, including Lamiophlomis rotata, Oxytropis falcate Bunge, Curcuma longa Linn, and Myricaria bracteata. Two of these herbs (Lamiophlomis rotate; Curcuma longa Linn) are commonly used in different formulae of Chinese medicine. The objective of this study is to use an interdisciplinary approach to test the hypothesis that the formula and its components influence the process of CSTI. METHODS: In vivo models have been established in 30 rabbit ear pinnae and studied for: (1) blood flow velocity (BFV) which was affected by pressure of 21.2 kg/cm2 for 30 second over the local rabbit ear tissue; (2) edema formation of the closed soft tissue injury; (3) in vivo local temperature change. RESULTS: The results of in vivo studies indicated that CSTI significantly increased the velocity of blood flow and increased edema formation within the control group. The PRP extracts for 5 hours significantly slowed down the BFV of CSTI in rabbit ears, markedly decreased the elevated edema level from the 3rd to the 5th day. CONCLUSION: The ingredients contained in the formula have positive effects in healing CSTI and further study is worth exploring.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Biological Dressings , Drugs, Chinese Herbal/administration & dosage , Edema/drug therapy , Pain/drug therapy , Soft Tissue Injuries/drug therapy , Administration, Topical , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacokinetics , Blood Flow Velocity/drug effects , Drugs, Chinese Herbal/pharmacology , Ear , Edema/etiology , Microcirculation/drug effects , Pain/etiology , Rabbits , Soft Tissue Injuries/complications , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL